Tag: Arix Bioscience

November 6, 2019 Off

Artios expands DDR pipeline with new asset

By Dino Mustafić

Arix Bioscience said Wednesday that its portfolio company Artios Pharma Ltd, has entered in-licensing agreement of a small-molecule ATR inhibitor programme from The University of Texas MD Anderson Cancer Center and ShangPharma.

May 19, 2017 Off

Arix bags $65 million in a B series investment round

By Dino Mustafić

Arix Bioscience on Friday said that its new business group, Iterum, has raised $65 million by closing a Series B investment round. “Arix is delighted to have led this $65m funding round comprising many of the biotech sector’s leading specialist investors,” said…